13 September 2024 in Cancer Epidemiology, Biomarkers & Prevention
Background: Vigorous physical activity has been associated with lower risk of fatal prostate cancer. However, mechanisms contributing to this relationship are not understood. Methods: We studied 117 men with prostate cancer in the University of North Carolina Cancer Survivorship Cohort (UNC CSC) who underwent radical prostatectomy and 101 radiation-treated patients with prostate cancer in FASTMAN. Structured questionnaires administered in UNC CSC assessed physical activity. In both studies, digital image analysis of hematoxylin and eosin–stained tissues was applied to quantify tumor-infiltrating lymphocytes in segmented regions. NanoString gene expression profiling in UNC CSC and microarray in FASTMAN were performed on tumor tissue, and a 50-gene signature utilized to predict immune cell types. Results: Vigorous recreational activity, reported by 34 (29.1%) UNC CSC men, was inversely associated with tumor-infiltrating lymphocyte abundance. Tumors of men reporting any vigorous activity versus none showed lower gene expression–predicted abundance of Th, exhausted CD4 T cells, and macrophages. T-cell subsets, including regulatory T cells, Th, Tfh, exhausted CD4 T cells, and macrophages, were associated with an increased risk of biochemical recurrence, only among men with ERG-positive tumors. Conclusions: Vigorous activity was associated with lower prostate tumor inflammation and immune microenvironment differences. Macrophages and T-cell subsets, including those with immunosuppressive roles and those with lower abundance in men reporting vigorous exercise, were associated with worse outcomes in ERG-positive prostate cancer. Impact: Our novel findings contribute to our understanding of the role of the tumor immune microenvironment in prostate cancer progression and may provide insights into how vigorous exercise could affect prostate tumor biology.
29 October 2026 in Cancer Epidemiology, Biomarkers & Prevention
Background: Higher periprostatic adipose tissue (PPAT) quantity has been associated with increased prostate cancer aggressiveness. However, PPAT definitions vary between studies, and few have examined associations of PPAT with tumor biology. Methods: Using radiation-planning computed tomography scans from 316 patients with prostate cancer treated with androgen deprivation therapy at the Northern Ireland Cancer Centre, we contoured PPAT according to three anatomic definitions. Associations of adipose tissue quantity and density (continuous measures and tertiles) with disease aggressiveness (Gleason grade ≥4 + 3 vs. ≤3 + 4) were examined using logistic regression. Exploratory gene set enrichment analysis identified PPAT-associated pathways enriched in prostate tumors. Results: Among men with prostate cancer, an elevated total quantity of pelvic adipose tissue [T3 vs. T1 fully adjusted odds ratio (OR), 1.97; 95% confidence interval (CI), 1.10–3.56] and higher density of PPAT in closest proximity to the prostate (T3 vs. T1 fully adjusted OR, 2.36; 95% CI, 1.00–5.68) were associated with increased odds of high-grade disease. Higher waist circumference was also associated with increased tumor aggressiveness (T3 vs. T1 fully adjusted OR, 1.99; 95% CI, 1.04–3.86). Men with a higher quantity of total pelvic adipose tissue had enriched glucose and lipid signaling-related pathways in their tumors. Conclusions: Greater total pelvic adipose tissue quantity and higher PPAT density were associated with increased tumor aggressiveness among men with prostate cancer. Exploratory analyses identified tumor glucose and lipid metabolism as potential contributing mechanisms. Impact: Our findings support a potential role for PPAT in prostate cancer aggressiveness. Associations of increased PPAT density with higher tumor grade and of a higher quantity of pelvic fat with enhanced tumor glucose and lipid signaling suggest potential contributing mechanisms to be explored in future studies.